Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Peptidoglycan recognition proteins

a technology of peptidoglycans and recognition proteins, applied in the field of new drugs, can solve the problems of weight loss in cancer patients, and achieve the effect of regulating the growth activity of keratinocytes and preventing septic shock

Inactive Publication Date: 2006-01-05
HUMAN GENOME SCI INC
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0025] In another aspect, a method for identifying PGRP-K, PGRP-W, or PGRP-C receptors is provided, as well as a screening assay for agonists and antagonists using such receptors. This assay involves determining the effect a candidate compound has on PGRP-K, PGRP-W, or PGRP-C binding to the PGRP-K, PGRP-W, or PGRP-C receptor. In particular, the method involves contacting a PGRP-K, PGRP-W, or PGRP-C receptor with an PGRP-K, PGRP-W, or PGRP-C polypeptide and a candidate compound and determining whether PGRP-K, PGRP-W, or PGRP-C polypeptide binding to the PGRP-K, PGRP-W, or PGRP-C receptor is increased or decreased due to the presence of the candidate compound. The antagonists may be employed to prevent septic shock, inflammation, and to regulate the growth activity of keratinocytes.

Problems solved by technology

A major problem in cancer patients is weight loss, usually associated with anorexia.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Peptidoglycan recognition proteins
  • Peptidoglycan recognition proteins
  • Peptidoglycan recognition proteins

Examples

Experimental program
Comparison scheme
Effect test

example 1

Isolation of PGRP-K, PGRP-W, and / or PGRP-C cDNA Clone(s) from the Deposited Sample(s)

[0303] The cDNA for PGRP-K (ATCC Accession No: 203564) is inserted into the Sal I and Not I multiple cloning site of pCMVSport 2.0 (Life Technologies). pCMVSport 2.0 contains an ampicillin resistance gene and may be transformed into E. coli strain DH10B, available from Life Technologies. (See, for instance, Gruber, C. E., et al., Focus 15:59-(1993).)

[0304] The cDNA for PGRP-W (ATCC Accession No: 203563) is inserted into the Sal I and Not I multiple cloning site of pCMVSport 3.0 (Life Technologies). pCMVSport 3.0 contains an ampicillin resistance gene and may be transformed into E. coli strain DH10B, available from Life Technologies. (See, for instance, Gruber, C. E., et al., Focus 15:59-(1993).)

[0305] The cDNA for PGRP-C (ATCC Accession No: 209683) is inserted into the EcoRI and Xho I multiple cloning site of Uni-Zap XR (Stratagene). Uni-Zap XR contains an ampicillin resistance gene and may be tr...

example 2

Isolation of PGRP-K, PGRP-W, or PGRP-C Genomic Clones

[0313] A human genomic P1 library (Genomic Systems, Inc.) is screened by PCR using primers selected for the cDNA sequences corresponding to SEQ ID NO:1, SEQ ID NO:3, or SEQ ID NO:5, according to the method described in Example 1. (See also, Sambrook.)

example 3

Chromosomal Mapping of PGRP-K, PGRP-W, or PGRP-C

[0314] An oligonucleotide primer set is designed according to the sequence at the 5′end of SEQ ID NO:1, SEQ ID NO:3, or SEQ ID NO:5. This primer preferably spans about 100 nucleotides. This primer set is then used in a polymerase chain reaction under the following set of conditions: 30 seconds, 95 degree C.; 1 minute, 56 degree C; 1 minute, 70 degree C. This cycle is repeated 32 times followed by one 5 minute cycle at 70 degree C. Human, mouse, and hamster DNA is used as template in addition to a somatic cell hybrid panel containing individual chromosomes or chromosome fragments (Bios, Inc). The reactions is analyzed on either 8% polyacrylamide gels or 3.5% agarose gels. Chromosome mapping is determined by the presence of an approximately 100 bp PCR fragment in the particular somatic cell hybrid.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention related to three novel recognition protein expressed by keratinocytes, wound-healing tissues and chondrosarcoma tissue. More specifically, isolated nucleic acid molecules are provided encoding human peptidoglycan recognition protein-related proteins, referred to herein as PGRP-K (Keratinocytes), PGRP-W (Wound-healing), and PGRP-C (Chondrosarcoma) of FIGS. 1A-B, FIGS. 2A-C, and FIG. 3, respectively, each having homology to both human peptidoglycan recognition protein (PGRP) as well as murine Tag-7. PGRP-K, PGRP-W, and PGRP-C polypeptides are also provided. Further provided are vectors, host cells and recombinant methods for producing the same. The invention also relates to both the inhibition and enhancement of activities of PGRP-K, PGRP-W, and PGRP-C polypeptides and diagnostic methods for detecting PGRP-K, PGRP-W, and PGRP-C gene expression.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS [0001] This application is a Divisional of U.S. application Ser. No. 10 / 180,454, filed Jun. 27, 2002, which is a Divisional of U.S. application Ser. No. 09 / 469,242, filed Dec. 22, 1999, now U.S. Pat. No. 6,444,790, which claims benefit under 35 U.S.C. §119(e) of U.S. Application No. 60 / 113,809, filed Dec. 23, 1998, all of which are incorporated herein by reference in their entirety.FIELD OF THE INVENTION [0002] The present invention relates to three novel peptidoglycan recognition binding proteins expressed by keratinocytes, wound-healing tissues and chondrosarcoma tissue. More specifically, isolated nucleic acid molecules are provided encoding human peptidoglycan recognition protein-related proteins, referred to herein as PGRP-K (Keratinocytes), PGRP-W (Wound-healing), and PGRP-C (Chondrosarcoma) of FIGS. 1A-B, FIGS. 2A-C, and FIG. 3, respectively, each having homology to both human peptidoglycan recognition protein (PGRP) as well as murine T...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12Q1/68C07H21/04C12P21/06C07K14/705C07K16/28G01N33/50A61K31/7088A61K38/00A61K48/00A61P31/04A61P31/12A61P35/00A61P35/04A61P37/02A61P43/00C07K14/47C07K16/18C12N1/15C12N1/19C12N1/21C12N5/10C12N15/09C12P21/02C12Q1/02G01N33/15G01N33/53G01N33/566
CPCC07K14/47A61K38/00A61P31/04A61P31/12A61P35/00A61P35/04A61P37/02A61P43/00
Inventor YOUNG, PAULRUBEN, STEVENROSEN, CRAIGOLSEN, HENRIK
Owner HUMAN GENOME SCI INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com